A Study on Pigmentation Disorders in Children

January 4, 2024 updated by: Abal Baral, Nepal Health Research Council

A Retrospective Study on Pigmentation Disorders in Children in a Tertiary Care Children's Hospital.

The descriptive cross-sectional study was undertaken at Kanti Children's Hospital during the period from January 2020 to June 2021. Ethical approval for the study was obtained from the Institutional Review Board of Kanti Children's Hospital (IRB-KCH). The refence number is 59/2020-021. The study focused on children with hyperpigmentation disorders presenting at the Dermatology Outpatient Department of Kanti Children's Hospital.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

299

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Nepal
      • Kathmandu, Nepal
        • Kanti Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Inclusive of children ranging from newborns to 15 years old with hyperpigmentation due to any cause, the study excluded those admitted to wards with alternative diagnoses

Description

Inclusion Criteria:

  • children ranging from newborns to 15 years old with hyperpigmentation due to any cause

Exclusion Criteria:

  • children admitted to wards

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Children with hyperpigmentation disorder
Children aged 0 to 15 with hyperpigmentation due to any cause presenting to Dermatology Outpatient Department of Kanti Children's Hospital

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure the age distribution of children with hyperpigmentation disorders
Time Frame: 1.5 years
The age (in years) of all the children with hyperpigmentation disorders presenting to the outpatient department of Kanti Children's Hospital was recorded. Outpatient hospital records were used for collecting the study variable.
1.5 years
Measure the gender distribution of children with hyperpigmentation disorders
Time Frame: 1.5 years
The gender (male or female) of all the children with hyperpigmentation disorders presenting to the outpatient department of Kanti Children's Hospital was recorded. Outpatient hospital records were used for collecting the study variable.
1.5 years
Measure the caste distribution of children with hyperpigmentation disorders
Time Frame: 1.5 years
The caste of all the children with hyperpigmentation disorders presenting to the outpatient department of Kanti Children's Hospital was recorded. Outpatient hospital records were used for collecting the study variable.
1.5 years
Measure the causes of hyperpigmentation in children aged 0 to 15
Time Frame: 1.5 years
Measure the prevalence of different causes of hyperpigmentation due to any cause in children aged 0 to 15 years presenting to the dermatology outpatient department of Kanti Children's Hospital. Outpatient hospital records were used for collecting the study variables.
1.5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Nepal Health Research Council

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Actual)

June 1, 2021

Study Completion (Actual)

June 1, 2021

Study Registration Dates

First Submitted

December 13, 2023

First Submitted That Met QC Criteria

December 30, 2023

First Posted (Actual)

January 5, 2024

Study Record Updates

Last Update Posted (Estimated)

January 8, 2024

Last Update Submitted That Met QC Criteria

January 4, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 59/2020-021

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hyperpigmentation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe